Evidence map›Paper›PMID 32414931›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Cooperatively enhanced reactivity and "stabilitaxis" of dissociating oligomeric proteins.

Jaime Agudo-Canalejo, Pierre Illien, Ramin Golestanian

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jaime Agudo-CanalejoDepartment of Living Matter Physics, Max Planck Institute for Dynamics and Self-Organization, D-37077 Göttingen, Germany.
Pierre IllienSorbonne Université, CNRS, Laboratoire Physicochimie des Electrolytes et Nanosystèmes Interfaciaux (PHENIX), UMR CNRS 8234, 75005 Paris, France.
Ramin GolestanianDepartment of Living Matter Physics, Max Planck Institute for Dynamics and Self-Organization, D-37077 Göttingen, Germany; ramin.golestanian@ds.mpg.de.ORCID 0000-0002-3149-4002

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many functional units in biology, such as enzymes or molecular motors, are composed of several subunits that can reversibly assemble and disassemble. This includes oligomeric proteins composed of several smaller monomers, as well as protein complexes assembled from a few proteins. By studying the generic spatial transport properties of such proteins, we investigate here whether their ability to reversibly associate and dissociate may confer on them a functional advantage with respect to nondissociating proteins. In uniform environments with position-independent association-dissociation, we find that enhanced diffusion in the monomeric state coupled to reassociation into the functional oligomeric form leads to enhanced reactivity with localized targets. In nonuniform environments with position-dependent association-dissociation, caused by, for example, spatial gradients of an inhibiting chemical, we find that dissociating proteins generically tend to accumulate in regions where they are most stable, a process that we term "stabilitaxis."

Indexed as

ProteinsCellular MicroenvironmentDiffusionDissociative DisordersModels, TheoreticalMultiprotein ComplexesPolymerizationProtein StabilityProtein TransportMultiprotein ComplexesProteinsfirst passageintracellular transportprotein complexesreactivityself-organization

Identifiers

PMID32414931
PMCPMC7275728

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.